IL86039A - Sulfonyldecahydro-8h- isoquino (2,1-g) (1,6) naphthyridines, optical isomers thereof, their preparation and pharmaceutical compositions containing them - Google Patents

Sulfonyldecahydro-8h- isoquino (2,1-g) (1,6) naphthyridines, optical isomers thereof, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL86039A
IL86039A IL86039A IL8603988A IL86039A IL 86039 A IL86039 A IL 86039A IL 86039 A IL86039 A IL 86039A IL 8603988 A IL8603988 A IL 8603988A IL 86039 A IL86039 A IL 86039A
Authority
IL
Israel
Prior art keywords
sulfonyldecahydro
isoquino
naphthyridines
preparation
lower alkyl
Prior art date
Application number
IL86039A
Other languages
English (en)
Other versions
IL86039A0 (en
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Priority to IL100114A priority Critical patent/IL100114A/xx
Publication of IL86039A0 publication Critical patent/IL86039A0/xx
Priority to IL100114A priority patent/IL100114A0/xx
Publication of IL86039A publication Critical patent/IL86039A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL86039A 1987-04-13 1988-04-12 Sulfonyldecahydro-8h- isoquino (2,1-g) (1,6) naphthyridines, optical isomers thereof, their preparation and pharmaceutical compositions containing them IL86039A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL100114A IL100114A (en) 1987-04-13 1988-04-12 (8ar, s, 12as, 13as)-decahydro - 8h-isoquino (2,1-g) (1,6) -naphthyridines and 12-sulfonyl derivatives thereof
IL100114A IL100114A0 (en) 1987-04-13 1991-11-21 Decahydro-8h-isoquino(2,1-g)(1,6)naphthyridines and sulfonyl derivatives thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/037,320 US4791108A (en) 1987-04-13 1987-04-13 Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers

Publications (2)

Publication Number Publication Date
IL86039A0 IL86039A0 (en) 1988-09-30
IL86039A true IL86039A (en) 1993-05-13

Family

ID=21893706

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86039A IL86039A (en) 1987-04-13 1988-04-12 Sulfonyldecahydro-8h- isoquino (2,1-g) (1,6) naphthyridines, optical isomers thereof, their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US4791108A (fi)
EP (1) EP0288196B1 (fi)
JP (1) JP2527784B2 (fi)
KR (1) KR960007864B1 (fi)
AT (1) ATE92066T1 (fi)
AU (1) AU613610B2 (fi)
CA (1) CA1331459C (fi)
DE (1) DE3882571T2 (fi)
DK (2) DK171106B1 (fi)
ES (1) ES2058264T3 (fi)
FI (1) FI88162C (fi)
HU (2) HU199469B (fi)
IE (1) IE60624B1 (fi)
IL (1) IL86039A (fi)
MX (1) MX11083A (fi)
NO (1) NO170805C (fi)
NZ (1) NZ224221A (fi)
PH (1) PH25961A (fi)
PT (1) PT87219B (fi)
ZA (1) ZA882562B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956365A (en) * 1987-04-13 1990-09-11 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds
US4886798A (en) * 1987-04-13 1989-12-12 Syntex (U.S.A.) Inc. Optical isomers of sulfonyldecahydro-8H-isoquino-(2,1-G)(1,6) naphthyridines and related compounds useful as α2 -blockers
US4960891A (en) * 1987-04-13 1990-10-02 Syntex (U.S.A.) Inc. Process for the preparation of decahydro-8H-isoquino[2,1-g][1,6]naphthyridine derivatives
GB9012469D0 (en) * 1990-06-05 1990-07-25 Glaxo Group Ltd Medicaments
US5231181A (en) * 1991-03-21 1993-07-27 Syntex (U.S.A.) Inc. Process for the preparation of (8as,12as,13as)-decahydroisoquino ((2,1-g) (1,6)-naphthyridin-8-one derivatives
NZ243586A (en) * 1991-07-17 1995-03-28 Syntex Inc Decahydrobenzo[a]pyrrolo[2,3-e]quinolizene and decahydro-8h-isoquino[2,1-g][1,6]naphthyreidine derivatives and pharmaceutical compositions thereof
US5229387A (en) * 1991-09-20 1993-07-20 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives
EP1483231A1 (de) * 2002-03-04 2004-12-08 Boehringer Ingelheim Pharma GmbH & Co.KG Neue salmeterol-zimtsäuresalze, verfahren zu deren herstellung und deren verwendung als arzneimittel
CN103387583B (zh) * 2012-05-09 2018-04-13 中国科学院上海药物研究所 二芳基并[a,g]喹嗪类化合物、其制备方法、药物组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953598A (en) * 1972-09-08 1976-04-27 The Upjohn Company Compounds, compositions and methods of use
GB1513824A (en) * 1975-05-22 1978-06-14 Wyeth John & Brother Ltd 1,3,4,6,7,11b-hexahydro-2h-benzo(a)quinolizine derivative
US4353911A (en) * 1979-07-20 1982-10-12 Andre Buzas Indolo(2,3-a)quinolizidines, useful in increasing femoral and vertebral blood flow
CH645653A5 (de) * 1980-08-01 1984-10-15 Ciba Geigy Ag Quaternaere, copolymere, hochmolekulare ammoniumsalze auf acrylbasis, deren herstellung und verwendung als aktive komponente in kosmetischen mitteln.
US4454139A (en) * 1980-08-28 1984-06-12 John Wyeth & Brother, Limited α2 -Adrenoceptor antagonistic benzoquinolizines
GB8302499D0 (en) * 1983-01-29 1983-03-02 Wyeth John & Brother Ltd Benzoquinolizines
US4690928A (en) * 1984-02-02 1987-09-01 Merck & Co., Inc. Substituted hexahydro arylquinolizines as α2 blockers
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility

Also Published As

Publication number Publication date
JPS63277679A (ja) 1988-11-15
HUT47107A (en) 1989-01-30
KR880012601A (ko) 1988-11-28
DE3882571D1 (de) 1993-09-02
IE881097L (en) 1988-10-13
DK199388A (da) 1988-10-14
IL86039A0 (en) 1988-09-30
NZ224221A (en) 1990-07-26
DE3882571T2 (de) 1994-01-20
NO170805B (no) 1992-08-31
PH25961A (en) 1992-01-13
NO170805C (no) 1992-12-09
DK84693D0 (da) 1993-07-15
ES2058264T3 (es) 1994-11-01
MX11083A (es) 1993-04-01
KR960007864B1 (ko) 1996-06-13
DK199388D0 (da) 1988-04-12
FI881687A0 (fi) 1988-04-12
ATE92066T1 (de) 1993-08-15
CA1331459C (en) 1994-08-16
AU1450288A (en) 1988-10-13
ZA882562B (en) 1989-12-27
PT87219B (pt) 1992-12-31
DK84693A (da) 1993-07-15
FI881687A (fi) 1988-10-14
HU199469B (en) 1990-02-28
EP0288196A1 (en) 1988-10-26
PT87219A (pt) 1988-05-01
JP2527784B2 (ja) 1996-08-28
NO881574D0 (no) 1988-04-12
EP0288196B1 (en) 1993-07-28
IE60624B1 (en) 1994-07-27
FI88162C (fi) 1993-04-13
US4791108A (en) 1988-12-13
FI88162B (fi) 1992-12-31
NO881574L (no) 1988-10-14
DK171106B1 (da) 1996-06-10
AU613610B2 (en) 1991-08-08
HU210349A9 (en) 1995-03-28

Similar Documents

Publication Publication Date Title
GB2126226B (en) Pyridine derivatives
NZ226354A (en) Azaspirane derivatives and pharmaceutical compositions
IL86039A (en) Sulfonyldecahydro-8h- isoquino (2,1-g) (1,6) naphthyridines, optical isomers thereof, their preparation and pharmaceutical compositions containing them
DE3362504D1 (en) 1-carboxyalkanoylindoline-2-carboxylic-acid esters, their preparation, pharmaceutical compositions containing them, and their therapeutic use
FI881816A (fi) Nya bicykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
DE3663660D1 (en) Û4.2.0¨bicyclooctane derivatives, process for their preparation and pharmaceutical compositions containing same
CA2007760A1 (fr) Nouveaux derives de benzonaphtyridine-1,8, leur preparation et les compositions qui les contiennent
ATE98961T1 (de) 1,8-benzonaphthyridinderivate und ihre herstellung.
IL87107A0 (en) Naphthothiazepine derivatives,their preparation and pharmaceutical compositions containing them
DE3160719D1 (en) Benzothiopyrano(2,3-c) pyridines and their acid addition salts, their preparation, their use as medicaments and compositions containing them

Legal Events

Date Code Title Description
RH Patent void